Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT04806633
What this trial is testing

Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention

Who this might be right for
Left Cardiac CatheterizationPercutaneous Coronary InterventionAcute Kidney Injury+1 more
G.Gennimatas General Hospital 1,722
Not applicableStudy completedNCT06902493
What this trial is testing

Impact of Prior SGLT2 Inhibitors Use on the Development and Progression of Sepsis-Associated Acute Kidney Injury

Who this might be right for
SepsisSeptic ShockAcute Kidney Injury
University of Jazan 664
Not applicableLooking for participantsNCT06283420
What this trial is testing

Metabolic Response to the Initiation of Heart Failure Therapy

Who this might be right for
Heart Failure
Vojtech Melenovsky, MD, PhD 120
Post-approval studies (Phase 4)Not Yet RecruitingNCT07351643
What this trial is testing

CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes in Non-diabetic ACS Patients Without HF

Who this might be right for
ACS (Acute Coronary Syndrome)SGLT2 Inhibitors
Shenyang Northern Hospital 110
Large-scale testing (Phase 3)Study completedNCT06065540
What this trial is testing

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Who this might be right for
Type 2 Diabetes Mellitus
Novo Nordisk A/S 2,734
Testing effectiveness (Phase 2)UnknownNCT04304560
What this trial is testing

Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial

Who this might be right for
Heart Failure With Reduced Ejection Fraction (HFrEF)Diabete Type 2Cardiomyopathies
Damanhour University 60
Early research (Phase 1)Looking for participantsNCT07076823
What this trial is testing

Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer

Who this might be right for
Colorectal CancerSGLT-2 Inhibitor
West China Hospital 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07421518
What this trial is testing

Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT-2 Inhibitors

Who this might be right for
Type 1 DiabetesType 2 Diabetes
AdventHealth Translational Research Institute 75
Post-approval studies (Phase 4)Looking for participantsNCT04662723
What this trial is testing

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

Who this might be right for
GlomerulonephritisImmunoglobulin A Nephropathy
Fondazione Schena 878
Not applicableStudy completedNCT02993614
What this trial is testing

Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors

Who this might be right for
Diabetes Mellitus Type 2
AstraZeneca 99,999
Testing effectiveness (Phase 2)UnknownNCT06113900
What this trial is testing

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Who this might be right for
Lupus Nephritis
Ain Shams University 50
Not applicableLooking for participantsNCT05770687
What this trial is testing

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

Who this might be right for
Myocardial InfarctionDiabetes Mellitus, Type 2
Kiyuk Chang 1,000
Not applicableNot Yet RecruitingNCT07348484
What this trial is testing

Urinary Biomarker-Based Diagnostic and Monitoring System for Chronic Kidney Disease and Real-World Effectiveness of SGLT2 Inhibitors

Who this might be right for
Chronic Kidney Disease
Instituto de Investigación Biomédica de Salamanca 300
Very early researchStudy completedNCT06812429
What this trial is testing

Effects of Sodium-Glucose Co-transporter 2 Inhibitors on Inflammation

Who this might be right for
Inflammation
Washington University School of Medicine 6
Not applicableUnknownNCT03917758
What this trial is testing

Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2Arterial HypertensionBody Weight Changes
University of Turin, Italy 30
Very early researchLooking for participantsNCT06229678
What this trial is testing

Ketones, SGLT2, HFrEF

Who this might be right for
Type2diabetesHeart Failure With Reduced Ejection Fraction
The University of Texas Health Science Center at San Antonio 71
Post-approval studies (Phase 4)Study completedNCT03871621
What this trial is testing

Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial

Who this might be right for
Type 2 Diabetes Mellitus
Mackay Memorial Hospital 76
Post-approval studies (Phase 4)Study completedNCT05139472
What this trial is testing

Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction

Who this might be right for
Heart Failure with Preserved Ejection FractionHeart Failure, DiastolicDiabetes Mellitus
University of Texas Southwestern Medical Center 8
Not applicableLooking for participantsNCT07157475
What this trial is testing

Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors

Who this might be right for
Peripheral Arterial Disease(PAD)
Wroclaw Medical University 300
Post-approval studies (Phase 4)Looking for participantsNCT06668389
What this trial is testing

Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial

Who this might be right for
Congenital Heart DiseaseRepaired Tetralogy of Fallot (rTOF)Pulmonary Regurgitation+2 more
The University of Hong Kong 106
Next Page